Neuromuscular physiology and pharmacology: An update

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 12, Issue 5, 2012, Pages 237-244

  Khirwadkar, Rashmi ^a   Hunter, Jennifer M ^b  

^a University Hospital   (United Kingdom)

^b Clinical Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866311744     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mks030     Document Type: Article

References (15)

1. Thams S, Brodin P, Plantman S. Classical major histocompatibility complex class 1 molecules in motorneurons: new actors at the neuromuscular junction. J Neurosci 2009; 29: 13503-15
2. Fagerlund MJ, Eriksson LI. Current concepts in neuromuscular transmission. Br J Anaesth 2009; 103: 108-14
3. Burden SJ. Snapshot: neuromuscular junction. Cell 2011; 144: 826
4. Savarese JJ, McGilvra JD, Sunaga H et al. Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double bonded) isoquinolinium diester compounds gantacurium (AV 430 A), CW 002, and CW 011. Anesthesiology 2010; 113: 58-73
5. Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth 2009; 103: 115-29
6. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM et al. Allergy to low dose sugammadex. Anaesthesia 2011; 66: 217-19
7. McDonnell NJ, Pavy TJG, Green LK et al. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011; 106: 199-201
8. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarising block (Part II). Br J Anaesth 1971; 43: 478-85
9. Berg H, Roed J, Viby-Mogensen J et al. Residual neuromuscular blockade is a risk factor for postoperative pulmonary complications. A prospective randomised and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-103
10. Eriksson LI, Sundman E, Olsson R et al. Functional assessment of the pharynx at rest and during swallowing in partially paralysed humans simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43
11. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of non-depolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98: 1042-8
12. Hayes AH, Mirakhur RK, Breslin DS et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56: 312-8
13. Fawcett WJ, Dash A, Francis GA et al. Recovery from neuromuscular block: residual curarisation following atracurium or vecuronium by bolus dosing or infusions. Acta Anaesthesiol Scand 1995; 39: 288-93
14. Murphy GS, Szokol JW, Marymount JH et al. Residual neuromuscular blockade and critical respiratory events in post anaesthetic care unit. Anesth Analg 2008; 107: 130-7
15. Kopman AF, Eikermann M. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia 2009; 64: 22-30